Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Arctic Bioscience AS – Notice of extraordinary general meeting: Marita Holstad proposed as new board member

The Board of Directors of Arctic Bioscience AS ("the "Company") has proposed Marita Holstad as new board member and the Board of Directors of the Company calls for an extraordinary general meeting (EGM) for the election.Marita Holstad has extensive experience from the pharmaceutical industry, and is currently Global Vice President, Commercialization Leader respiratory in GlaxoSmithKline (GSK), based in Chicago, IL. Before joining GSK, Marita Holstad has 16 years’ experience from AbbVie (previously Abbott) from management positions in Norway, UK and the US within Immunology across

6 reasons why your brand should communicate with emojis 💬

To bring back a slightly cliché, yet accurate saying:  ✨ A picture says more than a thousand words ✨  While emojis aren’t exactly pictures, they’re the closest you can get in text-format. Emojis are a great visual tool that can portray a wide array of emotions and help spice up your content. Here are six great reasons why you should leverage the power of emojis in your brand communication: 1. They help your text stand out 💥People have short attention spans, and they just keep getting shorter. We get bored easily, our brains are constantly looking for something to

Financial Report July – September 2021

Stockholm, Sweden, October 22, 2021(NYSE: ALV and SSE: ALIV.sdb)Q3 2021: Accelerating global supply chain disruptions Financial highlights Q3 2021 $1,847m net sales12% organic sales decline*5.4% operating margin5.6% adjusted operating margin*$0.68 EPS - a decrease of $0.44$0.73 adjusted EPS* - a decrease of $0.75 Full year 2021 indications Around 11% net sales growthAround 8% organic sales growthAround 8% adjusted operating margin  Key business developments in the third quarter of 2021 · Significant organic sales decline* as global LVP declined by 20%

Proact receives multiple partner awards from Dell Technologies

Dell Technologies selected Proact, Europe’s leading independent data centre and cloud services provider, as the winner for the categories of both Customer Experience in Finland and Excellence in Data Center Sales in Sweden during the Dell Technologies Partner Awards 2021. The awards confirm Proact’s leading position in the Central and Northern European market for data management and customer service.The prizes were bestowed during the Dell Technologies Partner Awards 2021 for Central and Northern Europe and recognise the highest-performing partners from a variety of categories. Each

ContextVision – Mandatory notification of trade – primary insider

STOCKHOLM – October 22, 2021 – Fredrik Palm, CEO of ContextVision, has on October 22[nd], 2021 purchased 2,500 shares in ContextVision AB at an average price of NOK 22.47 per share. After the transaction, Mr Palm holds a total of 30,700 shares in ContextVision AB. With reference to Section 4-2 of the Norwegian Securities Trading Act ("STA"), kindly note the following primary insider share transaction: Name of listed entity: ContextVision ABISIN number: SE0014731154Stock ticker: CONTXName of primary insider: Fredrik PalmRelation to listed entity: CEOTrade: 2,500 sharesDate:

Dignitana publishes October newsletter

Dignitana AB today publishes the October newsletter highlighting prominent media coverage for DigniCap and activities for Breast Cancer Awareness Month. To read the newsletter click here   or visit Dignitana.com .The Dignitana InBrief newsletter is published monthly and posted at www.dignitana.com as part of Dignitana's commitment to provide ongoing communication to the market. To receive future Dignitana news directly to your email,

New shares of Bioretec Ltd subscribed with option rights have been registered with the trade register

Bioretec Ltd                         Company announcement    22 October 2021 at 12.30 p.m.An aggregate number of 125,487 new shares of Bioretec Ltd have been subscribed for with option rights under option program 2021-1. The new shares have today on 22 October 2021 been registered with the trade register maintained by the Finnish Patent and Registration Office. The total subscription price of EUR 125.63 will be recorded in Bioretec's reserve of invested unrestricted equity, and the company's share capital remains unchanged. Following the registration of the new shares, the total number

Cell Impact reports third quarter results: Continued strong growth

Cell Impact AB (Nasdaq First North GM: CI B) reports the following financial summary for the third quarter.· Total revenues for the first quarter amounted to SEK 27.5 million, which is growth of 224 percent for the quarter. · Operating result was SEK -14.4 million (-5.7). · The Group's result after financial items was SEK -14.7 million (-6.1). · Earnings per share attributable to the shareholders of the Parent Company totaled SEK -0.25 (-0.12). · Equity was SEK 149.3 million (52.3) or SEK 2.54 per share (1.01) on the balance sheet date. · Debt/equity ratio was 73% (59%) on

Nordax Bank receives affirmed investment grade rating from Nordic Credit Rating (BBB, stable outlook)

Nordax Bank AB (publ) (“Nordax”) has, taking into consideration the acquisition of Bank Norwegian, received an affirmed investment grade rating from the rating institute Nordic Credit Rating with the rating BBB, stable outlook. To have a diversified funding structure is a cornerstone in Nordax’s funding strategy and reduces Nordax’s liquidity risk and enables it to create a larger, more optimal financing mix over time. Being an active issuer in the capital market is part of the strategy. The credit rating from Nordic Credit Rating further strengthens Nordax’s possibilities of getting

The Riksbank’s Business Survey: “As soon as you find one component, you realise you’re missing another”

Economic activity has continued to strengthen for major Swedish companies since the spring due to strong domestic and global demand. At the same time, there are major disruptions in output and deliveries, which are increasing costs and the need to raise sales prices.“The entire transport market is a bit shaky” For parts of the business sector, the supply problems have worsened since the Riksbank’s last survey this May. Parts of the manufacturing sector have periodically been forced to limit output due to logistics problems in combination with shortages of key components such as

New distributor in the US for LightAir

LightAir has signed a distribution agreement for the US market with market-leading Almo Corporation. The collaboration begins immediately with a first order for Swedish-developed air purifiers, valued at approximately SEK 2 million.Over the past six months, LightAir has established new partnerships with a handful of new distributors in a number of regions. The latest addition is Almo Corporation, which is the largest independent distributor of consumer products, as well as furniture and household appliances, in the United States. They work with over 2,000 independent dealers through eight

Smart mothers, the champions of learning

Learning must go on, even during a pandemic. When Indian schools were closed, Getinge’s partner Pratham mobilized mothers through phone-based outreach and resources, to enable them to become champions of learning. During the pandemic, large parts of India were in strict lockdowns and many schools in the Assam region were closed. For Getinge’s partner Pratham, an innovative learning organization working to improve the quality of education in India, there was no doubt: learning must go on. “A supportive learning environment at home can be a big contributor to the overall

Inwido AB’s Nomination Committee for the 2022 Annual General Meeting

Based on the ownership structure as of August 31, 2021 the largest shareholders in Inwido AB (publ) in terms of voting rights were consulted and expressed their desire to participate in the nomination process. The Nomination Committee has been appointed by Swedbank Robur Fund, the fourth AP Fund and the Lannebo Fund. Each has appointed a representative, as detailed below, who, together with Per Bertland, the chairman of the board, constitute Inwido´s Nomination Committee.Members of the Nomination Committee: Bo Lundgren, Swedbank Robur Fund (Chairman of the Nomination Committee) Thomas

Stockmann’s Interim report for January–September 2021 will be published as an Interim Management Statement

STOCKMANN plc, Other information disclosed according to the rules of the Exchange 22.10.2021 at 11.00 EETStockmann plc will publish its Interim report for January–September 2021 as a shorter Interim Management Statement. The publishing date and time will remain the same, 29 October 2021 at 8:00.The press and analyst briefing will be held on 29 October 2021 at 10:00 as a live webcast, that can be followed by this link  or on the address stockmanngroup.com.  The recording and presentation material

Invitation to Pexip Capital Markets Day

(Oslo, Norway, October 22, 2021) Pexip Holding ASA (“Pexip”, Oslo Børs Ticker: PEXIP) invites investors, analysts, media and other stakeholders to a Capital Markets Day (CMD) on Thursday December 9 2021, from 09:00 to 11:30 CET. The event will take place at Oslo Konserthus (Lille Sal), Munkedamsveien 14, Oslo, Norway, and a live webcast of the event will also be streamed via https://investor.pexip.comEvent details for the Pexip Capital Markets Day 2021 Date: December 9, 2021 Time: 09:00 - 11:30 CET For registration to the event, please follow this link and select either in-person

BioStock: Targinta’s CEO on TARG10 and the spin-off

Targinta has selected its first drug candidate TARG10, which shows an inhibitory effect on tumour growth and reduced metastasis in triple-negative breast cancer. In addition, the company is in an intensive phase where it is preparing for a spin-off from the parent company Xintela. BioStock contacted Targinta’s CEO Per Norlén to learn more about TARG10 and the spin-off.Read the interview with Targinta's CEO Per Norlén at biostock.se: https://www.biostock.se/en/2021/10/targintas-ceo-on-targ10-and-the-spin-off/ This is a press release from BioStock - Connecting Innovation & Capital.

Nepa AB appoints Nomination Committee

STOCKHOLM, Sweden - Nepa, a leading consumer research and analytics company, providing insight solutions to strengthen brands and drive sales by increased marketing effectiveness, has had a Nomination Committee appointed for the company. Nepa AB’s four largest shareholders on September 30, 2021, have in consultation with the Chairman of the Board, Katarina Bonde, appointed the following representatives to serve on the Nomination Committee: - Ulrich Boyer, private investor - Marcus Wahlberg, representing Elementa - Ulrik Grönvall, representing Swedbank Robur - Niclas Öhman,

Irisity wins €0.5m SaaS contract to protect sites across the Netherlands.

Irisity AB (publ): In partnership with Spyke Security Irisity delivers video analytics technology to customers in the Netherlands, with an estimated order value of EUR 0.5 million. Due to the confidential nature of this relationship, and the security applications involved, we are unable to disclose any further details regarding end customers identity or the specifics of the projects. For further information: Andreas Höye, Irisity IR Phone: +46 769 01 34 51 E-mail: andreas.hoye@irisity.com

Publishing of Apetit Plc’s Business Review for January-September 2021

Apetit Plc, Press release, on 22 October 2021 at 10:00 a.m.Apetit Plc will publish its Business Review for January-September 2021 on Friday 29 October 2021 at 8.30 a.m. A separate press conference in relation to the Business Review will not be arranged.Apetit PlcFor further information, please contact:Sanna Väisänen, Director, Corporate Communications and Sustainability, tel. +358 10 402 4041Apetit is a food industry company firmly rooted in Finnish primary production. Our operations are based on a unique and sustainable value chain: we create well-being with vegetables by offering

Restructuring programme of Componenta Castings Ltd has ended

Componenta Corporation Stock Exchange Release, 22 October 2021 at 10:00 EEST The restructuring programme of Componenta Castings Ltd has ended upon the approval of the payment of restructuring debt carried out by the company on 15 October 2021 by the supervisor and the provision of the supervisor’s final account of the restructuring programme to creditors today on 22 October 2021. The Board of Directors of Componenta Corporation has on 13 October 2021 decided to end Componenta Castings Ltd’s (“Componenta Castings”) restructuring programme prematurely. Componenta Castings had previously

Introducing Virtual Lapland: a new way to experience the northern Finnish nature

Explore and enjoy a 3D Arctic environment by Only in LaplandVirtual Lapland is a breathtaking, free VR experience by Only in Lapland, enabling people around the world to immerse themselves in the seasons and sensations of the north. The fully computer-generated environment is a virtual representation of the last wilderness in Europe and offers interactive elements, information, and stories about Lapland, including an animated tale about the Northern Lights. Finnish Lapland's official travel channel, Only in Lapland teamed up with Zoan, the studio behind other popular virtual destinations,

Elicera Therapeutics appoints professor Gunilla Enblad, Key Opinion Leader within the fields of CAR T-cells and B-cell lymphoma, as scientific advisor

Gothenburg, October 22, 2021 - Elicera Therapeutics AB (publ), a clinical stage cell and gene therapy company that develops immunooncological treatments focusing on CAR T-cells and oncolytic viruses, announced today that it has appointed professor Gunilla Enblad, Key Opinion Leader within the fields of CAR T-cells and B-cell lymphoma, as scientific advisor to the company.Dr. Gunilla Enblad is a Senior Consultant in Oncology since 2000 and was Head of Department at the Oncology Clinic at Uppsala University Hospital between 2004 and 2012. Enblad is Professor in Oncology at Uppsala University

There are no items matching the current filter
There are no more items matching the current filter
Back to top